Nasdaq
$78.17▲ 0.31%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $30.16BShares out 3.900M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
31- 5d agoAfter-hours26.10.20 07:424Ownership#●●●
DEXCOM INC
Dexcom Inc executive Michael Jon Brown filed a Form 4 on October 19, 2026, reporting changes in beneficial ownership of securities as of October 15, 2026. This filing serves as a standard disclosure of insider transaction activity.…more
$78.17+0.31%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 10.15After-hours26.10.16 05:02144Ownership
DEXCOM INC
Michael Jon Brown, an insider at Dexcom Inc., has filed an SEC Form 144 to report the proposed sale of company shares. This is a standard regulatory filing disclosing the insider's plan to dispose of their holdings.…more
$78.17+0.31%vs prev closeView filingShare - 9.30After-hours26.10.01 05:154Ownership
DEXCOM INC
DexCom, Inc. insider Sadie Stern filed a Form 4 on September 30, 2026, reporting a change in beneficial ownership of securities effective September 28, 2026. This filing serves as a routine disclosure regarding the executive's holdings.…more
$78.17+0.31%vs prev closeView filingShare
30 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 10.14After-hours26.10.15 06:13#●●●#●●●
DexCom's CGM Clinical Study Published in NEJM, Validating Efficacy
DexCom's G7 continuous glucose monitoring system demonstrated significant A1C reduction in Type 2 diabetes patients in a study published in the New England Journal of Medicine. The findings support the clinical value of early CGM adoption for non-insulin-using patients.…more
$78.17+0.31%vs prev closeDetected5m · 30m · 60m · Next dayPLUSShareBenzinga
- 9.28Overnight26.09.28 16:17
●●●●●●●● ●●●●● ●●●●●●
Dexcom has become the official continuous glucose monitoring (CGM) partner for Team Novo Nordisk. The company also released a new report identifying key challenges in Type 2 diabetes care across eight countries.…more
$78.17+0.31%vs prev closeShareBenzinga - 9.14After-hours26.09.15 05:30
●●●●●●●● ●●●●● ●●●●●●
Dexcom has promoted CFO Jereme Sylvain to the position of COO, while he will continue to serve as the company's CFO. This leadership change reflects a consolidation of roles to potentially improve operational efficiency.…more
$78.17+0.31%vs prev closeShareBenzinga
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report